New patent for Astrazeneca drug LOKELMA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for LOKELMA
Annual Drug Patent Expirations for LOKELMA

Lokelma is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.

LOKELMA drug price trends.

This drug has one hundred and sixteen patent family members in thirty-five countries.

The generic ingredient in LOKELMA is sodium zirconium cyclosilicate. One supplier is listed for this compound. Additional details are available on the sodium zirconium cyclosilicate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top